SavedAdd your journal

Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2020 / Cilt: 54 - Sayı: 2

A Retrospective Analysis of Er:YAG Laser Treatment in Solar Lentigines: Our Clinical Observations

Ezgi AKTAŞ KARABAY
Neslihan FİŞEK İZCİ
Pages
193–196
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No side effects occurred.Conclusion: Er:YAG laser treatment may be an effective and safe optional modality for solar lentigines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To investigate the efficacy of erbium-doped yttrium aluminium garnet (Er:YAG) laser in the treatment of solar lentigines.Methods: A retrospective study was conducted on patients treated with the only Er:YAG laser.
📊
Key Findings & Data:In this study, 14 patients with multiplesolar lentigines before treatment were included.
💡
Conclusion & Impact:No side effects occurred.Conclusion: Er:YAG laser treatment may be an effective and safe optional modality for solar lentigines.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: To investigate the efficacy of erbium-doped yttrium aluminium garnet (Er:YAG) laser in the treatment of solar lentigines.Methods: A retrospective study was conducted on patients treated with the only Er:YAG laser. In this study, 14 patients with multiplesolar lentigines before treatment were included. Treatment parameters and all side effects were recorded. One independent, blindeddermatologist evaluated the clinical improvement and the patients also scored their satisfaction degree with the treatment.Results: The mean age of the patients was 41.07±7.16 years. The number of mean treatment session for each patient was 1.79±1.05.At the final visit, excellent improvement (76–100% clearance) was reached in eight (57.1%) patients, while good improvement (51-75% clearance) was achieved in five (35.7%) patients. Ten patients (71.4%) were very satisfied and four (28.5%) patients were satisfiedwith the results of the treatment. No side effects occurred.Conclusion: Er:YAG laser treatment may be an effective and safe optional modality for solar lentigines.

🔖

Cite This Article

KARABAY, E. A., İZCİ, N. F. (2020). A Retrospective Analysis of Er:YAG Laser Treatment in Solar Lentigines: Our Clinical Observations. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 54 - Sayı: 2, 193–196. https://ajindex.com/articles/363408

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Vachiramon V, Panmanee W, Techapichetvanich T, Chanprapaph K. Comparison of Q-switched Nd: YAG laser and fractional carbon dioxide laser for the treatment of solar lentigines in Asians. Lasers Surg Med 2016;48:354–9
  2. James WD, Berger TG, Elston DM. Andrews’ Diseases of the Skin Clinical Dermatology. 10th ed. Canada: WB Saunders Company; 2006
  3. Lallas A, Argenziano G, Moscarella E, Longo C, Simonetti V, Zalaudek I. Diagnosis and management of facial pigmented macules. Clin Dermatol 2014;32:94–100
  4. Ortonne JP, Pandya AG, Lui H, Hexsel D. Treatment of solar lentigines. J Am Acad Dermatol 2006;54:S262–71
  5. Polder KD, Landau JM, Vergilis-Kalner IJ, Goldberg LH, Friedman PM, Bruce S. Laser eradication of pigmented lesions: a review. Dermatol Surg 2011;37:572–95
  6. Fitzpatrick RE. CO2 and Er:YAG laser resurfacing: practical approaches. The use of lasers in dermatology. Dermatol Ther 2000;13:102–13
  7. Tian WC. Novel technique to treat melasma in Chinese: The combination of 2940-nm fractional Er:YAG and 1064-nm Q-switched Nd:YAG laser. J Cosmet Laser Ther 2016;18:72–4
  8. Lomeo G, Cassuto D, Scrmali L, Sirago P. Er:YAG versus CO2 ablative fractional resurfacing: a split face study. Abstract presented at American Society for Laser Medicine and Surgery Conference. Kissimmee, F; Apr 2008
  9. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869–71
  10. Campanati A, Giannoni M, Scalise A, De Blasio S, Giuliano A, Giuliodori K, et al. Efficacy and Safety of Topical Pidobenzone 4% as Adjuvant Treatment for Solar Lentigines: Result of a Randomized, Controlled, Clinical Trial. Dermatology 2016;232:478–83
  11. Seirafi H, Fateh S, Farnaghi F, Ehsani AH, Noormohammadpour P. Efficacy and safety of long-pulse pulsed dye laser delivered with compression versus cryotherapy for treatment of solar lentigines. Indian J Dermatol 2011;56:48–51
  12. Karsai S, Roos S, Hammes S, Raulin C. Pulsed dye laser: what's new in non-vascular lesions?. J Eur Acad Dermatol Venereol 2007;21:877–90
  13. Schoenewolf NL, Hafner J, Dummer R, Bogdan Allemann I. Laser treatment of solar lentigines on dorsum of hands: QS Ruby laser versus ablative CO2 fractional laser - a randomized controlled trial. Eur J Dermatol 2015;25:122–6
  14. Imhof L, Dummer R, Dreier J, Kolm I, Barysch MJ. A Prospective Trial Comparing Q-Switched Ruby Laser and a Triple Combination Skin-Lightening Cream in the Treatment of Solar Lentigines. Dermatol Surg 20